# NEXGEL, Inc. (NXGL)

> Source: Nexqual · https://nexqual.com/NXGL · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, NEXGEL, Inc. (NXGL), nexqual.com/NXGL" · informational, not investment advice.

**Price:** USD 5.18 (-5.13% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 5.46 · day 4.06–5.53 · 52w 3–57 · market cap $2.5M · NCM

## Key facts
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts).
- Total return with dividends: 1Y -89.0% vs S&P 500 +18.1%; 5Y -91.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-10, EPS estimate USD -4.8, revenue estimate $4.2M.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts.
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-24 | Maxim Group | Downgrade | Buy → Hold |  |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-12-20) |
|---|---|---|
| Total return | -89.0% | -91.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -89.1% | -40.3% |
| Volatility (annualized) | 125.4% | 76.0% |
| Max drawdown | -94.6% (Oct 2025→Oct 2026) | -96.3% (Dec 2024→Sep 2026) |

## Peers (Medical Instruments & Supplies)
KMTS (Kestra Medical Technologies, Lt) USD 28.68 +6.34% · XRAY (DENTSPLY SIRONA Inc.) USD 8.83 +3.76% · LMAT (LeMaitre Vascular, Inc.) USD 83.16 +1.97% · ATRC (AtriCure, Inc.) USD 57.78 +1.60% · WRBY (Warby Parker Inc.) USD 24.59 -7.28% · PLSE (Pulse Biosciences, Inc) USD 45.59 -6.08%

## More
Full page: https://nexqual.com/NXGL · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt